![]() |
WELCOME
Michael Landes, C.E.O. and President, Annenberg Center, Eisenhower Medical Center, Rancho Mirage, California |
||||
![]() |
WELCOME |
||||
![]() |
PKC-beta Inhibitor Therapy for Diabetic
Retinopathy |
|
|||
![]() |
Community Health Education for Diabetes
Self-Care |
||||
![]() |
Pharmacologic Vitreolysis in Diabetic Vitreo-Retinopathy |
|
|||
![]() |
Medico-Legal Aspects of Diabetic Eye Care
Howard Slavin, Esq., Lewis, D'Amato, Brisbois and Bisgaard LLP |
||||
![]() |
Neuro-Ophthalmic Manifestations of Diabetes
Alfredo A. Sadun, MD, PhD, Doheny Eye Institute |
|
|||
![]() |
Diabetic Vitreopathy & Retinopathy
J. Sebag, M.D., FACS, FRCOphth, University of Southern California |
|
|||
![]() |
Diabetes and Glaucoma Paul P. Lee, MD, JD, Duke Eye Center |
|
|||
![]() |
Medical Management of
Diabetes in 2002 Willa A. Hsueh, M.D., University of California, Los Angeles |
|
|||
![]() |
Lens Effects and Cataract Surgery in Diabetes Arthur Astorino, Jr., M.D.University of California, Los Angeles |
|
|||
![]() |
Improving Diabetes Quality of Care Paul Lee, MD, JD, Duke Eye Center |
|
|||
![]() |
Rosiglitizone Therapy for Diabetic Retinopathy Willa A. Hsueh, M.D., University of California, Los Angeles |
|